Eur J Pharmacol 440:269279 Meier JJ, Gallwitz B, Salmen S, Goetze O, Holst JJ, Schmidt WE, Nauck MA (2003a) Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes
A larger group loses little or no weight
Broader research on tracking weight loss on GLP-1s points to the same theme: self-monitoring your doses, weight, and habits predicts better long-term outcomes
By focusing on heart health, these initiatives aim to reduce the risks of heart disease and cardiac emergencies
With the Body Program, it brings that same trusted approach to weight loss, offering an easy, all-in-one plan that supports better metabolic health without cutting corners